Table 2.
Outpatient management and adherence patterns by nephrotic syndrome classification.
| Management | SSNS (n = 23) | FRNS/SDNS (n = 48) | SRNS (n = 16) | Total (n = 87) |
|---|---|---|---|---|
| Mean clinic visits per year (SD) | 2.59 (1.1) | 4.33 (1.7) | 4.71 (1.7) | 3.7 (2.0) |
| Immunosuppressive treatment | ||||
| Corticosteroids only | 23 (100) | 19 (40) | 4 (25) | 46 (53) |
| Mycophenolate mofetil | 0 (0) | 24 (50) | 6 (38) | 30 (34) |
| Cyclophosphamide | 0 (0) | 7 (15) | 2 (13) | 9 (10) |
| Tacrolimus | 0 (0) | 7 (15) | 3 (19) | 10 (11) |
| Cyclosporine | 0 (0) | 2 (4) | 8 (50) | 10 (11) |
| >1 agents in addition to corticosteroids | 0 (0) | 10 (21) | 4 (25) | 14 (16) |
| Medication adherence | ||||
| Adherent | 18 (78) | 24 (50) | 8 (50) | 50 (57) |
| Nonadherent | 5 (22) | 24 (50) | 8 (50) | 37 (43) |
| Clinic follow-up adherence | ||||
| Adherent | 15 (65) | 35 (73) | 9 (56) | 60 (70) |
| Nonadherent | 8 (35) | 13 (27) | 7 (44) | 28 (32) |
|
| ||||
| Total (n = 71) | ||||
|
| ||||
| Urine monitoring | ||||
| Adherent | 15 (65) | 24 (50) | N/A | 39 (55) |
| Nonadherent | 8 (35) | 24 (50) | N/A | 32 (45) |
Data are presented as the number of patients with the percentage in parenthesis or mean and standard deviation in parenthesis.
FRNS, frequently relapsing nephrotic syndrome; MCD, minimal change disease; FSGS, focal segmental glomerulosclerosis; SD, standard deviation; SDNS, steroid-dependent nephrotic syndrome; SRNS, steroid-resistant nephrotic syndrome; SSNS, steroid-sensitive and infrequently relapsing nephrotic syndrome.